Testosterone-stimulated growth of the rat prostate may be driven by tissue hypoxia and hypoxia-inducible factor-1α

Journal of Endocrinology

Volumn 196, Issue 1, 2008, Pages 11-19

  Rudolfsson, Stina Häggström ^a   Bergh, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PIMONIDAZOLE; TESTOSTERONE; VASCULOTROPIN; VASCULOTROPIN A; BIOLOGICAL MARKER; CARBONATE DEHYDRATASE; CARBONIC ANHYDRASE IX, RAT; MESSENGER RNA; NITROIMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CELL HYPOXIA; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYPOXEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE VENTRAL LOBE; PROTEIN SYNTHESIS; RAT; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAINING; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; ORCHIECTOMY; PHYSIOLOGY; PROSTATE; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; BIOLOGICAL MARKERS; CARBONIC ANHYDRASES; CELL HYPOXIA; EPITHELIAL CELLS; GENE EXPRESSION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; NITROIMIDAZOLES; ORCHIECTOMY; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TESTOSTERONE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38849209350     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-07-0272     Document Type: Article

References (42)

1. Arteel GE, Thurman RG, Yates JM & Raleigh JA 1995 Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. British Journal of Cancer 72 889-895.
2. Banerjee PP, Banerjee S, Tilly KI, Tilly JL, Brown TR & Zirkin BR 1995 Lobe-specific apoptotic cell death in rat prostate after androgen ablation by castration. Endocrinology 136 4368-4376.
3. Bennewith KL & Durand RE 2004 Quantifying transient hypoxia in human tumor xenografts by flow cytometry. Cancer Research 64 6183-6189.
4. Berger AP, Horninger W, Bektic J, Pelzer A, Spranger R, Bartsch G & Frauscher F 2006 Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease? BJU International 98 587-590.
5. Buttyan R, Ghafar MA & Shabsigh A 2000 The effects of androgen deprivation on the prostate gland: cell death mediated by vascular regression. Current Opinion in Urology 10 415-420.
6. Chou S-C, Flood PM & Raleigh JA 1996 Marking hypoxic cells for complement and cytotoxic T lymphocyte-mediated lysis: using pimonidazole. British Journal of Cancer 74 213-216.
7. Dor Y, Proat R & Keshet E 2001 Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. American Journal of Physiology and Cell Physiology 280 C1367-C1374.
8. Folkman J 1998 Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence Endocrinology 139 441-442.
9. Franck Lissbrant I, Häggström S, Damber JE & Bergh A 1998 Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology 139 451-456.
10. Ghafar MA, Puchner PJ, Anastasiadis AG, Cabelin MA & Buttyan R 2002 Does the proscatic vascular system contribute to the development of benign prostatic hyperplasia? Current Urology Reports 3 292-296.
11. Giordano FJ & Johnson RS 2001 Angiogenesis: the role of the microenviromnent in flipping the switch. Current Opinion in Genetics and Development 11 35-40.
12. Hager M, Mikuz G, Bartsch G, Kolbitsch C & Moser PL 2006 The association between local atherosclerosis and prostate cancer. British Journal of Urology 99 46-48.
13. Häggström S, Franck Lissbrant I, Bergh A & Damber JE 1999 Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. Journal of Urology 161 1620-1625.
14. Häggström S, Stattin P, Wikström P, Bergh A & Damber JE 2001 Castration-induced reduction of vascular endothelial growth factor expression in benign human prostate tissue is lost in advanced prostate cancer. BJU International 88 110-116.
15. Hammarsten P, Rudolfsson SH, Henriksson R, Wikstrom P & Bergh A 2007 Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats. Prostate 67 573-581.
16. Harvey H 1995 A unifying hypthesis that links benign prostate hyperplasia and prostatic intraepithelial neoplasia with prostate cancer. Pathology, Research and Practice 191 924-934.
17. Isaacs JT, Furuya Y & Berges R 1994 The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostate tissue. Seminars in Cancer Biology 5 391-400.
18. Johansson A, Rudolfsson SH, Wikstrom P & Bergh A 2005 Altered levels of angiopoietin 1 and tie 2 are associated with androgen-regulated vascular regression and growth in the ventral prostate in adult mice and rats. Endocrinology 146 3463-3470.
19. Joseph IB, Nelson JB, Denmeade SR & Isaacs JT 1997 Androgens regulate vascular endotheliall growth factor content in normal and malignant prostatic tissue. Clinical Cancer Research 3 2507-2511.
20. Kimbro KS & Simons JW 2006 Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocrine-Related Cancer 13 739-749.
21. Kurita T, Wang YZ, Donjacour AA, Zhao C, Lydon JP, O'Malley BW, Isaacs JT, Dahiya R & Cunha GR 2001 Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive organs. Cell Death and Differentiation 8 192-200.
22. Laughner E, Taghavi P, Chiles K, Mahon PC & Semenza GL 2001 HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Molecular and Cellular Biology 21 3995-4004.
23. Lee C 1981 Physiology of castration-induced regression in rat prostate. In The Prostatic Cell: Structure and Function Part A. New York: AR Liss.
24. Lee YM, Jeong C-H, Koo S-Y, Son JM, Song HS, Bae S-K, Raleigh JA, Chung H-Y, Yoo M-A & Yim K-W 2001 Determination of hypoxic regions by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Developmental Dynamics 220 175-186.
25. Lekås E, Johansson M, Widmark A, Bergh A & Damber JE 1997 Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration. Urological Research 25 309-314.
26. Lekås E, Engstrand C, Bergh A & Damber JE 1999 Transient ischemia induces apoptosis in the ventral prostate of the rat. Urological Research 27 174-179.
27. Lissbrant IF, Lissbrant E, Damber JE & Bergh A 2001 Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer. Scandinavian Journal of Urology and Nephrology 35 437-452.
28. Lissbrant IF, Hammarsten P, Lissbrant E, Ferrara N, Rudolfsson SH & Bergh A 2004 Neutralizing VEGF bioactivity with a soluble chimeric VEGF receptor protein flt(1-3)IgG inhibits testosterone stimulated prostate growth in castrated mice. Prostate 58 57-65.
29. Mabjeesh NJ, Willard MT, Frederickson CE, Zong H & Simons J 2003 Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3′-kinase/ protein kinase B in prostate cancer cells. Clinical Cancer Research 9 2416-2425.
30. Movsas B, Chapman JD, Hanlon AL, Horwitz EM, Pinover WH, Greenberg RE, Stobbe C & Hanks GE 2001 Hypoxia in human prostate carcinoma. American Journal of Clinical Oncology 24 458-461.
31. Park SY, Kim YJ, Gao AC, Mohler JL, Onate SA, Hidalgo AA, Ip C, Park EM, Yoon SY & Park YM 2006 Hypoxia increases androgen receptor activity in prostate cancer cells. Cancer Research 15 5121-5129.
32. Pore N, Jiang Z, Gupta A, Cerniglia G, Kao GD & Maity A 2006 EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms. Cancer Research 66 3197-3204.
33. Raleigh JA, Chou SC, Bono EL, Thrall DE & Varia MA 2001 Semiquantitative immunohistochemical analysis for hypoxia in human tumors. International Journal of Radiation Oncology, Biology, Physics 49 569-574.
34. Ravindranath N, Wion D, Bracher P & Djakiew D 2001 Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate. Journal of Andrology 22 432-443.
35. Semensa GL 2003 Targeting HIF-1 for cancer therapy. Nature Reviews. Cancer 3 721-732.
36. Sensibar JA, Alger B, Tseng A, Berg L & Lee C 1990 Proteins of the rat prostate. III. Effect of testosterone on protein synthesis by the ventral prostate of castrated rats. Journal of Urology 143 161-166.
37. Shabisgh A, Tanji N, D'Agati V, Burchardt M, Rubin M, Goluboff ET, Heitjan D, Kiss A & Buttyan R 1999 Early efects of castration on the vascular system of the rat ventral prostate gland. Endocrinology 140 1920-1926.
38. Shabsigh A, Ghafar MA, de la Taille A, Burchardt M, Kaplan SA, Anastasiadis AG & Butyan R 2001 Biomarker analysis demonstrates a hypoxic environment in the castrated rat ventral prostate gland. Journal of Cellular Biochemistry 81 437-444.
39. Sordello S, Bertrand N & Plouet J 1998 Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens. Biochemical and Biophysical Research Communications 251 287-290.
40. Stewart RJ, Panigrahy D, Flynn E & Folkman J 2001 Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. Journal of Urology 165 688-693.
41. Yin M, Zhong Z, Connor HD, Bunzendahl H, Finn WF, Rusy I, Li X, Raleigh JA, Mason RP & Thurman RG 2002 Protective efect of glycine on renal injury induced by ischemia-reperfusion in vivo. American Journal of Physiology 282 F417-F423.
42. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW & Semenza GL 2000 Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Research 15 1541-1545.